These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 31548100)

  • 21. 226
    Aartsma-Rus A; Ferlini A; McNally EM; Spitali P; Sweeney HL;
    Neuromuscul Disord; 2018 Jan; 28(1):77-86. PubMed ID: 29203356
    [No Abstract]   [Full Text] [Related]  

  • 22. Transition in Duchenne muscular dystrophy: An expert meeting report and description of transition needs in an emergent patient population: (Parent Project Muscular Dystrophy Transition Expert Meeting 17-18 June 2011, Amsterdam, The Netherlands).
    Schrans DG; Abbott D; Peay HL; Pangalila RF; Vroom E; Goemans N; Vles JS; Aldenkamp AP; Hendriksen JG;
    Neuromuscul Disord; 2013 Mar; 23(3):283-6. PubMed ID: 22989602
    [No Abstract]   [Full Text] [Related]  

  • 23. 195th ENMC International Workshop: Newborn screening for Duchenne muscular dystrophy 14-16th December, 2012, Naarden, The Netherlands.
    Ellis JA; Vroom E; Muntoni F
    Neuromuscul Disord; 2013 Aug; 23(8):682-9. PubMed ID: 23791627
    [No Abstract]   [Full Text] [Related]  

  • 24. Transforming Duchenne care: meeting 25-26 June 2012, Ft. Lauderdale, Florida, USA.
    Kinnett K; Cripe LH
    Neuromuscul Disord; 2013 Aug; 23(8):690-5. PubMed ID: 23770103
    [No Abstract]   [Full Text] [Related]  

  • 25. Meeting on data sharing for Duchenne 21-22 March 2019 Amsterdam, the Netherlands.
    Verhaart IEC; 't Hoen PAC; Roos M; Vroom E;
    Neuromuscul Disord; 2019 Oct; 29(10):800-810. PubMed ID: 31548100
    [No Abstract]   [Full Text] [Related]  

  • 26. How Patient Organizations Can Drive FAIR Data Efforts to Facilitate Research and Health Care: A Report of the Virtual Second International Meeting on Duchenne Data Sharing, March 3, 2021.
    van Lin N; Paliouras G; Vroom E; 't Hoen PAC; Roos M
    J Neuromuscul Dis; 2021; 8(6):1097-1108. PubMed ID: 34334415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Duchenne and Becker muscular dystrophies.
    Flanigan KM
    Neurol Clin; 2014 Aug; 32(3):671-88, viii. PubMed ID: 25037084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of Duchenne muscular dystrophy (DMD) for the pediatricians in the community.
    Verma S; Anziska Y; Cracco J
    Clin Pediatr (Phila); 2010 Nov; 49(11):1011-7. PubMed ID: 20724320
    [No Abstract]   [Full Text] [Related]  

  • 29. Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions.
    Spurney CF
    Muscle Nerve; 2011 Jul; 44(1):8-19. PubMed ID: 21674516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk Factors for Cerebral Infarction in Duchenne Muscular Dystrophy: Review With our 2 Cases.
    Nozaki F; Kusunoki T; Kumada T; Shibata M; Fujii T
    J Stroke Cerebrovasc Dis; 2019 Sep; 28(9):2453-2458. PubMed ID: 31311695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Duchenne muscular dystrophy: issues in expanding newborn screening.
    Kemper AR; Wake MA
    Curr Opin Pediatr; 2007 Dec; 19(6):700-4. PubMed ID: 18025940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 128th ENMC International Workshop on 'Preclinical optimization and Phase I/II Clinical Trials Using Antisense Oligonucleotides in Duchenne Muscular Dystrophy' 22-24 October 2004, Naarden, The Netherlands.
    Muntoni F; Bushby K; van Ommen G
    Neuromuscul Disord; 2005 Jun; 15(6):450-7. PubMed ID: 15907292
    [No Abstract]   [Full Text] [Related]  

  • 33. Technology insight: therapy for Duchenne muscular dystrophy-an opportunity for personalized medicine?
    Lim LE; Rando TA
    Nat Clin Pract Neurol; 2008 Mar; 4(3):149-58. PubMed ID: 18268530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Frontline studies on Duchenne muscular dystrophy treatment].
    Matsuo M
    No To Hattatsu; 2009 Mar; 41(2):92-5. PubMed ID: 19517771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bridging the Gap: An Osteopathic Primary Care-Centered Approach to Duchenne Muscular Dystrophy.
    Carls C; Krajacic P
    J Am Osteopath Assoc; 2017 Jun; 117(6):377-385. PubMed ID: 28556860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Exon skipping therapy for Duchenne muscular dystrophy: outcome of preclinical study and prospective for clinical study].
    Nakamura A; Takeda S
    No To Hattatsu; 2010 Mar; 42(2):117-23. PubMed ID: 23858595
    [No Abstract]   [Full Text] [Related]  

  • 37. Diagnosis and cell-based therapy for Duchenne muscular dystrophy in humans, mice, and zebrafish.
    Kunkel LM; Bachrach E; Bennett RR; Guyon J; Steffen L
    J Hum Genet; 2006; 51(5):397-406. PubMed ID: 16583129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Muscular dystrophy.
    Roland EH
    Pediatr Rev; 2000 Jul; 21(7):233-7; quiz 238. PubMed ID: 10878185
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.